Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness
Go back to Opus Genetics Announces FDA Clearance of IND Application for OPGx-RDH12 Gene Therapy for Inherited Childhood Blindness| Diversified Corporate Resources, Inc. (NASDAQ: IRD) | Delayed: 3.82 -0.3 (7.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.12 | 52 Week High | $0.02 | |||
| Open | $4.04 | 52 Week Low | $0.02 | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.80 | EPS | $0.00 | |||
| Volume | 894,737 | |||||



